Alpharetta, GA, United States of America

R Martin Emanuel

This inventor holds 1 USPTO granted patent. Top assignee: Cytrx Corporation. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: R Martin Emanuel. Retrieved from https://idiyas.com/inventor/r-martin-emanuel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: R Martin Emanuel: Innovator in Gene Therapy

Introduction

R Martin Emanuel is a notable inventor based in Alpharetta, GA (US). He has made significant contributions to the field of gene therapy through his innovative work. His expertise and dedication to advancing medical science are evident in his patented inventions.

Latest Patents

R Martin Emanuel holds a patent for "Adjuvants and copolymer compositions." This invention comprises novel polyoxyethylene/polyoxypropylene block copolymer compositions and compounds. The compositions consist of block copolymers that are high molecular weight molecules, which are useful in gene therapy methods. This patent highlights his commitment to developing effective solutions in the medical field.

Career Highlights

Emanuel is associated with Cytrx Corporation, where he applies his knowledge and skills to further research and development in biotechnology. His work at the company has positioned him as a key player in the advancement of therapeutic technologies.

Collaborations

Some of his coworkers include Mannarsamy Balasubramanian and Mark Joseph Newman. Their collaboration fosters a dynamic environment for innovation and research.

Conclusion

R Martin Emanuel's contributions to gene therapy through his patented inventions and work at Cytrx Corporation underscore his importance in the field of biotechnology. His innovative spirit continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…